Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. | MicrobiomeTrials← Back to trialsNCT07148830
Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-04-01Est. Completion: 2027-04-01
Enrollment target: 100 participants Locations- Liver and GIT hospital , Minia University, Minya, Minya Governorate, Egypt
Other microbiome trials you might be interested in
Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal Adenocarcinoma
The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…
Maidstone, United KingdomEst. completion Feb 2, 2028
Pancreatic Cancer
The survival rate for patients with pancreatic cancer remains at a dismal 10% or less at 5 years, and although trials in…
Aurora, United StatesEst. completion Jun 30, 2029